Live Quote · NASDAQFUSNHealthcare· Biotechnology

Fusion Pharmaceuticals Inc.

$21.55 0.14%(+$0.03)
TickerSpark Score
73/100
Solid
40
Valuation
40
Profitability
100
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FUSN research report →

52-Week Range100% of range
Low
$2.31
Current
$21.55
High
$21.60
Company Overviewfusionpharma.com

About the company

Fusion Pharmaceuticals Inc. is a clinical-stage oncology enterprise focused on creating precise radiopharmaceutical therapies. The company utilizes its groundbreaking Targeted Alpha Therapies platform, which incorporates its exclusive Fast-Clear linker technology.

CEO
John F. Valliant
IPO
2020
Employees
101
HQ
Hamilton, ON, CA

Price Chart

+306.60% · this period
$21.55$11.96$2.37Jun 05Dec 04Jun 04
Valuation
Market Cap
$1.83B
P/E
-14.86
P/S
886.38
P/B
6.36
EV/EBITDA
-20.79
Div Yield
0.00%
Profitability
Gross Margin
34.96%
Op Margin
-4798.45%
Net Margin
-4588.83%
ROE
-49.34%
ROIC
-36.25%
Growth & Income
Revenue
$2.07M · 41.55%
Net Income
$-94,897,000 · -8.32%
EPS
$-1.45 · 27.50%
Op Income
$-99,232,000
FCF YoY
-13.62%
Performance & Tape
52W High
$21.60
52W Low
$2.31
50D MA
$21.39
200D MA
$10.42
Beta
-0.69
Avg Volume
1.97M

Get TickerSpark's AI analysis on FUSN

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 4, 24Bitetti Teresa Mariesell34,000
Jun 4, 24GANNON STEVENsell56,400
Jun 4, 24GANNON STEVENsell17,000
Jun 4, 24GANNON STEVENsell17,000
Jun 4, 24GANNON STEVENsell17,000
Jun 4, 24GANNON STEVENsell141,011
Jun 4, 24GANNON STEVENsell30,000
Jun 4, 24Valliant Johnsell192,200
Jun 4, 24Valliant Johnsell336,000
Jun 4, 24Valliant Johnsell500,000
Coverage · FUSN

Our FUSN coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on FUSN yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate FUSN report →
Internal Compare

Similar companies

Peers in the same neighborhood.